References
- Fletcher RJ. Food sources of phyto-oestrogens and their precursors in Europe. Br J Nutr 2003; 89 Suppl 1:S39-43; PMID:12725655; http://dx.doi.org/10.1079/BJN2002740
- Cornwell T, Cohick W, Raskin I: Dietary phytoestrogens and health. Phytochemistry 2004; 65(8):995-1016
- Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutri 2001; 131:1362s-75s; PMID:11285356
- Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003; 133(4):1027-35; PMID:12672914
- Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr 2010; 140(7):1355S-62S; PMID:20519412; http://dx.doi.org/10.3945/jn.109.119776
- Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr 2010; 140(7):1363S-8S; PMID:20519411; http://dx.doi.org/10.3945/jn.109.119784
- Setchell KD, Brown NM, Summer S, King EC, Heubi JE, Cole S, Guy T, Hokin B. Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults. J Nutr 2013; 143(12):1950-8; PMID:24089421; http://dx.doi.org/10.3945/jn.113.179564
- Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors α and β. Bioorg Med Chem 2004; 12(6):1559-67; PMID:15018930; http://dx.doi.org/10.1016/j.bmc.2003.11.035
- Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der BB, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139(10):4252-63; PMID:9751507
- Shinkaruk S, Carreau C, Flouriot G, Bennetau-Pelissero C, Potier M. Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity. Nutrients 2010; 2(3):340-54; PMID:22254026; http://dx.doi.org/10.3390/nu2030340
- Dutertre M, Smith CL. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 2000; 295(2):431-7; PMID:11046073
- Brzezinski A, Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999; 85(1):47-51; PMID:10428321; http://dx.doi.org/10.1016/S0301-2115(98)00281-4
- Pugazhendhi D, Watson KA, Mills S, Botting N, Pope GS, Darbre PD. Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells. J Endocrinol 2008; 197(3):503-15; PMID:18492816; http://dx.doi.org/10.1677/JOE-07-0384
- Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011, 127(3-5):204-15; PMID:21899826; http://dx.doi.org/10.1016/j.jsbmb.2011.08.007
- Jeng YJ, Kochukov MY, Watson CS. Membrane estrogen receptor-α-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal 2009; 4:2; PMID:19400946; http://dx.doi.org/10.1186/1750-2187-4-2
- Jeng YJ, Kochukov M, Nauduri D, Kaphalia BS, Watson CS. Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol - pituitary tumor induction in Fischer 344 rats. NutrMetab (Lond) 2010; 7:40; http://dx.doi.org/10.1186/1743-7075-7-40
- Ruggiero RJ, Likis FE. Estrogen: physiology, pharmacology, and formulations for replacement therapy. J Midwifery Womens Health 2002; 47(3):130-8; PMID:12071379; http://dx.doi.org/10.1016/S1526-9523(02)00233-7
- Bilal I, Chowdhury A, Davidson J, Whitehead S. Phytoestrogens and prevention of breast cancer: The contentious debate. World J Clin Oncol 2014; 5(4):705-12; PMID:25302172; http://dx.doi.org/10.5306/wjco.v5.i4.705
- Hwang KA, Choi KC. Anticarcinogenic effects of dietary phytoestrogens and their chemopreventive mechanisms. Nutr Cancer 2015; 67(5):796-803; PMID:25996655; http://dx.doi.org/10.1080/01635581.2015.1040516
- Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Gronberg H, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 2006; 17(2):169-80; PMID:16425095; http://dx.doi.org/10.1007/s10552-005-0342-2
- Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E: Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20(2):308-17; PMID:21098648; http://dx.doi.org/10.1158/1055-9965.EPI-10-0752
- Sirtori CR, Arnoldi A, Johnson SK: Phytoestrogens: end of a tale? Ann Med 2005; 37(6):423-38; PMID:16203615; http://dx.doi.org/10.1080/07853890510044586
- Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85(22):1819-27; PMID:8230262; http://dx.doi.org/10.1093/jnci/85.22.1819
- Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo MJ, Castelo-Branco C, Chantre P, Duran M, Haya J, et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 2002; 9(2):85-92; PMID:11995954
- Bhakta D, Higgins CD, Sevak L, Mangtani P, Adlercreutz H, McMichael AJ, dos Santos Silva I. Phyto-oestrogen intake and plasma concentrations in South Asian and native British women resident in England. Br J Nutr 2006; 95(6):1150-8; PMID:16768838; http://dx.doi.org/10.1079/BJN20061777
- Adlercreutz H, Hamalainen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT: Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989; 49(3):433-42; PMID:2923075
- Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990; 201:3-23; PMID:2173856; http://dx.doi.org/10.1080/00365519009085798
- Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997; 29(2):95-120; PMID:9187225; http://dx.doi.org/10.3109/07853899709113696
- Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 2004; 134(5):1207S-12S; PMID:15113973
- Heinonen SM, Hoikkala A, Wahala K, Adlercreutz H. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 2003; 87(4-5):285-99; PMID:14698210; http://dx.doi.org/10.1016/j.jsbmb.2003.09.003
- Watson CS, Bulayeva NN, Wozniak AL, Finnerty CC. Signaling from the membrane via membrane estrogen receptor-α: estrogens, xenoestrogens, and phytoestrogens. Steroids 2005; 70(5-7):364-71; PMID:15862819; http://dx.doi.org/10.1016/j.steroids.2005.03.002
- Watson CS, Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 1999; 220(1):9-19; PMID:9893163; http://dx.doi.org/10.3181/00379727-220-44338
- Watson CS, Jeng YJ, Kochukov MY. Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci 2010; 115(1):1-11; PMID:19955490; http://dx.doi.org/10.1093/toxsci/kfp288
- Jeng YJ, Watson CS. Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases. BMC Cancer 2009; 9:334; PMID:19765307; http://dx.doi.org/10.1186/1471-2407-9-334
- Vinas R, Jeng YJ, Watson CS. Non-genomic effects of xenoestrogen mixtures. Int J Environ Res Public Health 2012; 9(8):2694-714; PMID:23066391; http://dx.doi.org/10.3390/ijerph9082694
- Watson CS, Jeng Y-J, Guptarak J. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol 2011; 127(1-2):44-50; PMID:21300151; http://dx.doi.org/10.1016/j.jsbmb.2011.01.015
- Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: Influence of habitual diet. Proc Society Exp Biol Med 1998; 217(3):335-9; PMID:9492344; http://dx.doi.org/10.3181/00379727-217-44241
- Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012; 33(3):378-455; PMID:22419778; http://dx.doi.org/10.1210/er.2011-1050
- Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009; 30(1):75-95; PMID:19074586; http://dx.doi.org/10.1210/er.2008-0021
- Vandenberg LN. Low-dose effects of hormones and endocrine disruptors. Vitam Horm 2014; 94:129-65; PMID:24388189; http://dx.doi.org/10.1016/B978-0-12-800095-3.00005-5
- Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol 2012; 64(1):130-3; PMID:22750031; http://dx.doi.org/10.1016/j.yrtph.2012.06.015
- Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptor-enriched GH3/B6 cells have an enhanced non-genomic response to estrogen. Endocrine 1995; 3:743-9; PMID:21153164; http://dx.doi.org/10.1007/BF03000207
- Campbell CH, Watson CS. A comparison of membrane vs. intracellular estrogen receptor-α in GH(3)/B6 pituitary tumor cells using a quantitative plate immunoassay. Steroids 2001; 66(10):727-36; PMID:11522334; http://dx.doi.org/10.1016/S0039-128X(01)00106-4
- Bulayeva NN, Watson CS. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ Health Perspect 2004; 112(15):1481-7
- Vinas R, Watson CS. Mixtures of xenoestrogens disrupt estradiol-induced nongenomic signaling and functions in pituitary cells. BMC Environmental Health 2013; 12:26
- Watson C, Jeng YJ, Kochukov M. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 2008; 22(9):3328-36; PMID:18541692; http://dx.doi.org/10.1096/fj.08-107672
- Bulayeva NN, Gametchu B, Watson CS. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 2004; 69(3):181-92; PMID:15072920; http://dx.doi.org/10.1016/j.steroids.2003.12.003
- Zivadinovic D, Watson CS. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 2005; 7(1):R130-44; PMID:15642162; http://dx.doi.org/10.1186/bcr959
- Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007; 72(2):124-34; PMID:17174995; http://dx.doi.org/10.1016/j.steroids.2006.11.002
- Watson CS, Alyea RA, Jeng YJ, Kochukov MY. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 2007; 274(1-2):1-7; PMID:17601655; http://dx.doi.org/10.1016/j.mce.2007.05.011
- Kochukov MY, Jeng YJ, Watson CS. Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Env Health Perspect 2009; 117(5):723-30; http://dx.doi.org/10.1289/ehp.0800182
- Alyea RA, Watson CS. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci 2009; 10:59; PMID:19531209; http://dx.doi.org/10.1186/1471-2202-10-59
- Jeng YJ, Kochukov M, Watson CS. Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Environ Health 2010; 9:61; PMID:20950447; http://dx.doi.org/10.1186/1476-069X-9-61
- Jeng YJ, Watson CS. Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Environ Health Perspect 2011; 119(1):104-12
- Watson CS, Jeng YJ, Guptarak J. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Bio Chem Mol Biol 2011; 127(1-2):44-50
- Watson CS, Jeng YJ, Hu G, Wozniak A, Bulayeva N, Guptarak J. Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-alphai and caveolin I. Steroids 2011; 77(5):424-32; PMID:22230296
- Vinas R, Watson CS. Rapid estrogenic signaling activities of modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A. Endocri Disruptors 2013; 1(1):e26306; PMID:24795899; http://dx.doi.org/10.4161/endo.25411
- Vinas R, Watson C. Bisphenol s disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect 2013; 121(3):352-8; PMID:23458715; http://dx.doi.org/10.1289/ehp.1205826
- Koong LY, Watson CS: Direct estradiol and diethylstilbestrol actions on early- vs. late-stage prostate cancer cells. Prostate 2014; 74(16):1589-603
- Koong LY, Watson CS. Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells. Endocrine Disruptors 2015; 3(1): e995003; http://dx.doi.org/10.4161/23273747.2014.995003.
- Alyea R, Laurence S, Kim S, Katzenellenbogen B, Katzenellenbogen J, Watson C. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neuro Chem 2008; 106:1525-33
- Narita M, Miyagawa K, Mizuo K, Yoshida T, Suzuki T. Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect. Neuro Sci Lett 2006; 402(3):249-52
- Watson CS, Hu G, Paulucci-Holthauzen AA. Rapid actions of xenoestrogens disrupt normal estrogenic signaling. Steroids 2014; 81:36-42
- Zivadinovic D, Gametchu B, Watson CS. Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 2005; 7(1):R101-12; http://dx.doi.org/10.1186/bcr958
- Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 2000; 14(9):1434-47
- Marquez DC, Pietras RJ. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 2001; 20(39):5420-30
- Zarate S, Jaita G, Zaldivar V, Radl DB, Eijo G, Ferraris J, Pisera D, Seilicovich A. Estrogens exert a rapid apoptotic action in anterior pituitary cells. Am J Physiol Endocrinol Metab 2009; 296(4):E664-71
- Christian HC, Morris JF. Rapid actions of 17beta-oestradiol on a subset of lactotrophs in the rat pituitary. J Physiol 2002; 539(Pt 2):557-66
- Otto C, Fuchs I, Altmann H, Klewer M, Schwarz G, Bohlmann R, Nguyen D, Zorn L, Vonk R, Prelle K, et al. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J Steroid BiochemMolBiol 2008; 111(1-2):95-100
- Lee HR, Hwang KA, Choi KC. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models. Int J Oncol 2014; 45(2):595-602
- Alyea RA, Watson CS. Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol. Environ Health Perspect 2009; 117(5):778-83; http://dx.doi.org/10.1289/ehp.0800026
- Bulayeva NN, Wozniak A, Lash LL, Watson CS. Mechanisms of membrane estrogen receptor-{α}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am J Physiol Endocrinol Metab 2005; 288:E388-97
- Kits KS, Mansvelder HD. Regulation of exocytosis in neuroendocrine cells: spatial organization of channels and vesicles, stimulus-secretion coupling, calcium buffers and modulation. Brain Res Brain Res Rev 2000; 33(1):78-94
- Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003; 24(1):1-27
- Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002; 12(1):9-18
- Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 2008; 22(4):954-65
- Roskoski R, Jr. ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol Res 2012; 66(2):105-43
- Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence. FEBS J 2010; 277(1):2-21; PMID:19843174; http://dx.doi.org/10.1111/j.1742-4658.2009.07366.x
- Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol 2008; 630:189-205; http://dx.doi.org/10.1007/978-0-387-78818-0_12
- Valentin-Blasini L, Blount BC, Caudill SP, Needham LL: Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 2003; 13(4):276-82; http://dx.doi.org/10.1038/sj.jea.7500278
- Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, Setchell KD. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 2010; 31(5):886-93
- Watson CS, Jeng YJ, Bulayeva NN, Finnerty CC, Koong LY, Zivadinovic D, Alyea RA, Midoro-Horiuti T, Goldblum RM, Anastasio NC, et al. Multi-well plate immunoassays for measuring signaling protein activations/deactivations and membrane vs. intracellular receptor levels. Methods Mol Biol 2014; 1204:123-33; http://dx.doi.org/10.1007/978-1-4939-1346-6_11
- Lottering ML, Haag M, Seegers JC. Effects of 17b-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 1992; 52:5926-32